Page last updated: 2024-11-01

ofloxacin and Amputation, Traumatic

ofloxacin has been researched along with Amputation, Traumatic in 1 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Amputation, Traumatic: Loss of a limb or other bodily appendage by accidental injury.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Son, D1
Han, K1
Chang, DW1

Other Studies

1 other study available for ofloxacin and Amputation, Traumatic

ArticleYear
Extending the limits of fingertip composite grafting with moist-exposed dressing.
    International wound journal, 2005, Volume: 2, Issue:4

    Topics: Administration, Topical; Adolescent; Adult; Amputation, Traumatic; Anti-Bacterial Agents; Child; Chi

2005